enterochromaffi n-like (ECL) cells may be involved in the pathogenesis of carcinoid tumors [2] .
We describe a patient with gastric carcinoid tumors and hypergastrinemia who underwent radioguided surgery with the use of a somatostatin analog. Differential diagnosis suggested early-stage CAG-A with lack of acid production by hypertrophic parietal cells [3, 4] .
The Ethics Committee of Jichi Medical University approved the peripheral blood/tumor DNA analysis (No. 01-37) and the protocol for radioguided surgery using Octreo Scan (Mallinkrodt-Tyco, Petten, Holland) (No. 03-74). Written informed consent was obtained from the patient.
Case report
The patient was a 30-year-old man. The family history was not contributory. He had previously received Helicobacter pylori eradication therapy. A routine medical checkup with upper gastrointestinal barium examination showed multiple polypoid lesions in the stomach. Endoscopy revealed pedunculated polypoid lesions, measuring 30 mm in the upper portion of the gastric body and 20 mm in the lower portion of the gastric body (Fig. 1) . Biopsy suggested carcinoids. In addition, many small protruding carcinoid tumors, measuring approximately 5 mm, were detected in the stomach. The peripheral blood level of gastrin was 2400 ng/ml (normal range, 200 ng/ml or less). Neither brain computed tomography (CT) nor cervical echography revealed any evidence of tumor. There was no loss of heterozygosity (LOH) at the MEN1 gene in DNA collected from peripheral blood. On four-point biopsy (updated Sydney system), the patient was negative for H. pylori, with no mucosal atrophy. Only mild infl ammation was present; these fi ndings did not suggest typical CAG-A.
Abdominal CT showed no evidence of a pancreatic tumor. However, a microgastrinoma was considered as
Introduction
Gastric carcinoid tumors (GCTs) are classifi ed into three types based on pathogenesis and underlying factors [1] : type I, autoimmune gastritis (AIG) with atrophy of the gastric fundic gland region and hypergastrinemia, complicated by type A chronic atrophic gastritis (CAG-A); type II, GCTs associated with multiple endocrine neoplasia (MEN)-Zollinger-Ellison syndrome; and type III, sporadic GCTs. Type I and II lesions cause hypergastrinemia, and hyperplasia of a potential cause of the hypergastrinemia. Selective arteriography and a calcium-loading test were performed. There were no hypervascular lesions in the pancreas or duodenum. The gastrin level was high after hepatic, perirenal, and peripancreatic arterial loading.
A test with a somatostatin analog, diethylenetriamine pentaacetic acid (DTPA)-D-Phe1-octreotide (pentetreotide), labeled with 111 In (Octreo Scan; MallinkrodtTyco), showed high uptake at two points adjacent to the stomach (Fig. 2) . Laparotomy was performed 20 h after the intravenous injection of this somatostatin analog. With the use of a hand-held NAVIGATOR GPS system (Tyco, U.S. Surgical, Norwalk, CT, USA), the energydistinguishing circuit was matched to 111 In. On the Octreo Scan test, two uptake sites were present in the gastric wall, with counts ranging from 100 to 130. There were no high-count sites in the pancreas or at its periphery. Total gastrectomy with regional lymph node dissection was performed; the resected specimen is shown in Fig. 3 . The extirpated specimen was photographed by a nuclear medicine procedure. We confi rmed that the carcinoids at the two uptake sites had been completely extirpated.
Microscopically, the two pedunculated polyps consisted of small uniform cells that had central nuclei with no mitotic activity or necrosis. Rosette-like formations were recognized, suggesting carcinoid tumors (Fig. 4) . The neoplastic cells infi ltrated into the submucosa. Neither lymphatic vessel permeation nor lymph node metastasis was detected. Small tumors diffusely scattered in the gastric mucosa were composed of endocrine-cell micronests measuring 0.5 mm or less. Immunohistochemically, the pedunculated polyps and micronests were diffusely positive for chromogranin A and synaptophysin, and negative for gastrin. In the antrum, neither intestinal metaplasia nor infl ammatory cells were detected. Gastrin-positive cells were increased. Parietal cells in the gastric fundic glands showed hyperplasia (Fig. 5) . There was no LOH at the MEN1 gene in tumor or normal gastric mucosa.
Immediately after surgery, the patient's gastrin level decreased to the normal range. There has been no tumor recurrence or hypergastrinemia during 3 years of follow-up.
Discussion
Type A chronic atrophic gastritis (CAG-A) causes marked atrophy of the gastric fundic gland and absence of acidity, leading to hypergastrinemia [5] . Gastric carcinoid tumors (GCTs) are the most frequent complication of CAG-A, occurring in 65% to 75% of cases [6] . The incidence of GCTs in patients with MEN-ZollingerEllison syndrome ranges from 5% to 10%. Carcinoids may develop via hypergastrinemia and hyperplasia in ECL cells [2] , as demonstrated for CAG-A. In our patient, biopsy of the gastric body showed no mucosal atrophy. Given the patient's age, we assumed that the presence of gastrinoma was involved in the pathogenesis of the GCTs, without diagnosing CAG-A. Selective angiography and a calcium-loading test were performed. However, the presence or absence of microgastrinoma could not be ascertained.
Owing to the risk of lymph node metastasis, we decided to perform regional lymph node dissection and gastrectomy to treat the carcinoids in the gastric body, which measured 30 mm and 20 mm, respectively, in the upper and lower portions [7] . During surgery, we evaluated the presence or absence of gastrinoma. Many gastrinoma lesions are small, and 7% to 33% are ectopic, i.e., they are present in extrapancreatic locations [8] . Therefore, when suspected lesions are not found on CT and magnetic resonance imaging, intraoperative echography and loading tests must be performed [9] .
Patients with gastrinoma have increased expression of somatostatin receptors (SSRs) [10] . Octreo Scan may be more useful than other diagnostic imaging procedures for the localization of gastrinomas and the detection of microtumors [11] . Woltering et al. [12] successfully detected an occult gastrinoma with an intraoperative gamma probe. We used Octreo Scan, an accurate and noninvasive technique, to evaluate the presence or absence of occult gastrinoma. GCTs have SSRs, and SSR scintigraphy has a high diagnostic accuracy for GCTs [13] . Rodriguez et al. [14] described Octreo Scanguided total resection of a pulmonary carcinoid tumor, done with the use of a gamma probe. Several studies have provided evidence that Octreo Scan is useful for the intraoperative diagnosis of carcinoids and microgastrinomas [12] [13] [14] [15] . However, in the abdominal cavity, especially in the liver and around the spleen, analog uptake is high, making it diffi cult to differentiate tumors from normal tissue in some cases; radioguided surgery thus remains controversial [16] . In our patient, Octreo Scan uptake was detected in the pancreas and at its periphery. However, the count was not high, and uptake was uniform. Therefore, the possibility of gastrinoma could be ruled out, and we confi rmed that the two sites of increased uptake were the gastric carcinoids. Typical macroscopic fi ndings of GCTs show an elevated or submucosal tumor with a small depression of the top. The pedunculated tumors in the present patient seemed to be a rare and peculiar form.
Primary carcinoids may develop not only in the stomach and large intestine but also in the small intestine, in which detection is diffi cult [17] . The localization of microgastrinomas and insulinomas is often challenging. Adjusting the direction of a hand-held probe may facilitate differentiation between normal tissue and high-count areas. Probe-guided techniques using Octreo Scan may be useful for the intraoperative diagnosis of digestive hormone-producing tumors involving SSRs, such as neuroendocrine gastroenteropancreatic tumors.
Experimental studies have shown that H. pylori infection causes atrophy of the gastric mucosa and hypergastrinemia, leading to carcinoid formation [18] . Sato et al. [19] reported an association between H. pylori infection-related atrophy of the gastric mucosa and GCTs in Japanese patients without CAG-A. Our patient had a history of H. pylori infection and eradication therapy 6 months previously. Histologically, however, there was no atrophy of the gastric mucosa. Therefore, the H. pylori infection may not have had a role in the pathogenesis of the GCTs. The histopathological fi ndings included hyperplasia of parietal cells in the gastric fundic glands, consistent with the fi ndings of early-stage CAG-A reported by Torbenson et al. [3] and Stolte et al. [4] . Recently, Abraham et al. [20] (from the same group as Torbenson et al. [3] ) described a 54-year-old patient with achlorhydria, multiple GCTs, and parietal cell hyperplasia and referred to the case as "a new disorder". Our case appears to meet the criteria for earlystage CAG-A proposed by Torbenson et al. [3] and Stolte et al. [4] and may thus also be considered "a new disorder."
